IP Verse

Novel Compound, Production Method Therefor, And Pharmaceutical Composition

Patent No. EP4293013 (titled "Novel Compound, Production Method Therefor, And Pharmaceutical Composition") was filed by National Cancer Center on Jan 28, 2022. The application was issued on Aug 20, 2025.

Patent Summary

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 2, 2025
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Jul 24, 2025
Decision to grant a European patent
Jul 14, 2025
(Electronic) Receipt
Jul 14, 2025
French translation of claims
Jul 14, 2025
German translation of the claims
Jul 14, 2025
Letter accompanying subsequently filed items
Apr 17, 2025
Annex to the communication about intention to grant a European patent
Apr 17, 2025
Bibliographic data of the European patent application
Apr 17, 2025
Communication about intention to grant a European patent
Apr 17, 2025
Intention to grant (signatures)
Apr 17, 2025
Text intended for grant (clean copy)
Apr 17, 2025
Text intended for grant (version for approval)
Jan 29, 2025
(Electronic) Receipt
Jan 29, 2025
Amended description with annotations
Jan 29, 2025
Description
Jan 29, 2025
Letter accompanying subsequently filed items
Jan 29, 2025
Reply to communication from the Examining Division
Nov 8, 2024
Annex to the communication
Nov 8, 2024
Communication from the Examining Division
Nov 5, 2024
Examination started
Sep 17, 2024
(Electronic) Receipt
Sep 17, 2024
Amended claims filed after receipt of (European) search report
Sep 17, 2024
Amended claims with annotations
Sep 17, 2024
Amendments received before examination
Sep 17, 2024
Letter accompanying subsequently filed items
Jul 23, 2024
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Jul 4, 2024
Communication regarding the transmission of the European search report
Jul 4, 2024
European search opinion
Jul 4, 2024
Information on Search Strategy
Jul 4, 2024
Supplementary European search report
May 31, 2024
Search started
Nov 22, 2023
Notification of forthcoming publication
Aug 28, 2023
Copy of the international preliminary report on patentability
Aug 28, 2023
Translation of the international preliminary report on patentability
Aug 24, 2023
Information regarding early processing
Aug 4, 2023
(Electronic) Receipt
Aug 4, 2023
Abstract
Aug 4, 2023
Amended description filed after receipt of (European) search report
Aug 4, 2023
Amended description with annotations
Aug 4, 2023
Amendments received before examination
Aug 4, 2023
Claims
Aug 4, 2023
Description
Aug 4, 2023
Drawings
Aug 4, 2023
Request for entry into the European phase
Jun 23, 2023
Information on entry into European phase
Sep 5, 2022
Priority document (electronically transmitted)
Aug 18, 2022
Copy of the international search report
Aug 18, 2022
Copy of the translated international search report
Aug 18, 2022
International publication pamphlet

EP4293013

NATIONAL CANCER CENTER

Application Number: EP22752615A
Filing Date: Jan 28, 2022
Status: Granted And Under Opposition; Jul 18, 2025
Publication Date: Aug 20, 2025
External Links: Slate, Register , Google Patents